Patent Assignment
Reel/Frame 067951/0276
Assignment of Assignor's Interest
Recorded: 2024-07-10
Pages: 5
Assignor
DRACEN PHARMACEUTICALS, INC.
Executed: 2024-05-10
Assignee
GANYMEDE ONCOLOGY, INC.
BIOLABS SAN DIEGO, 9276 SCRANTON RD. SUITE 500, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(5)
NRF2 Protein Degraders
Application:
63/355,834 →
PCT:
PCT/US2023/069147 ↗
(Hetero)Aryl NRF2 Protein Degraders
Application:
63/614,288 →
Cycloalkylene NRF2 Protein Degraders
Application:
63/614,290 →
Amidocycloalkylene NRF2 Protein Degraders
Application:
63/614,294 →
(Hetero)Aryl and Indolinyl NRF2 Protein Degraders
Application:
63/614,308 →
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 21, 2023
From: MUNROE, JOHN EDWIN; WILD, ROBERT CHRISTIAN
To: DRACEN PHARMACEUTICALS, INC.
Reel/Frame 064014/0797 →
Security Interest
Jul 12, 2023
From: DRACEN PHARMACEUTICALS, INC.
To: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), AS COLLATERAL AGENT
Reel/Frame 064232/0765 →
Assignment of Assignor's Interest
Jul 13, 2023
From: MUNROE, JOHN EDWIN; WILD, ROBERT CHRISTIAN
To: DRACEN PHARMACEUTICALS, INC.
Reel/Frame 064248/0460 →
Assignment of Assignor's Interest
Feb 21, 2024
From: MUNROE, JOHN EDWIN
To: DRACEN PHARMACEUTICALS, INC.
Reel/Frame 066514/0602 →
Assignment of Assignor's Interest
Feb 21, 2024
From: MUNROE, JOHN EDWIN
To: DRACEN PHARMACEUTICALS, INC.
Reel/Frame 066513/0794 →
Assignment of Assignor's Interest
Feb 21, 2024
From: MUNROE, JOHN EDWIN
To: DRACEN PHARMACEUTICALS, INC.
Reel/Frame 066514/0594 →
Assignment of Assignor's Interest
Feb 21, 2024
From: MUNROE, JOHN EDWIN
To: DRACEN PHARMACEUTICALS, INC.
Reel/Frame 066514/0598 →
Release of Security Interest
May 14, 2024
From: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), AS COLLATERAL AGENT
To: DRACEN PHARMACEUTICALS, INC.
Reel/Frame 067405/0368 →